Jim Cramer: Merck is a buy after the drugmaker's post-earnings dip — here's why

Jim Cramer's daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio. Merck : The drugmaker reported a better-than-expected quarter. It raised its full-year sales outlook but was still a little short of estimates. The stock lost nearly 9%. Merck's acquisition of Acceleron and its pulmonary arterial hypertension treatment three years ago for $11.5 billion is about to pay off. The FDA approved it.

Not great. Not bad." PayPal : The digital payments company reported a better-than-expected quarter. The new CEO, Alex Chriss, knows what he's doing, Cramer said. "I would buy the stock." Howmet Aerospace : The maker of parts for the aerospace and transportation industries delivered a better-than-expected second quarter and the stock soared more than 13%. "The demand for anything aerospace is intense," Cramer said. "That means this company can make you money.

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Jim Cramer gives a tactical look at the market rotation out of tech stocksCNBC's Jim Cramer reminded investors of his classic adage: Keep a diverse portfolio.
La source: CNBC - 🏆 12. / 72 Lire la suite »

Jim Cramer's top 10 things to watch in the stock market TuesdayWall Street was mixed Tuesday, heading into the continued onslaught of tech earnings.
La source: CNBC - 🏆 12. / 72 Lire la suite »

Jim Cramer says the market rotation isn't all about smallcap stocksCramer said McDonald's managed to jump because the market is broadening, and investors were intrigued by the company's plan to bring in more customers.
La source: CNBC - 🏆 12. / 72 Lire la suite »

Jim Cramer's top 10 things to watch in the stock market MondayThe S&P 500 and Nasdaq were heading for a higher open Monday after a tough week.
La source: CNBC - 🏆 12. / 72 Lire la suite »